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Abstract: Calcium phosphate cements (CPCs) are clinically effective void fillers that are capable
of bridging calcified tissue defects and facilitating regeneration. However, CPCs are completely
synthetic/inorganic, unlike the calcium phosphate that is found in calcified tissues, and they lack
an architectural organization, controlled assembly mechanisms, and have moderate biomechanical
strength, which limits their clinical effectiveness. Herein, we describe a new class of bioinspired CPCs
that can glue tissues together and bond tissues to metallic and polymeric biomaterials. Surprisingly,
alpha tricalcium phosphate cements that are modified with simple phosphorylated amino acid
monomers of phosphoserine (PM-CPCs) bond tissues up to 40-fold stronger (2.5–4 MPa) than
commercial cyanoacrylates (0.1 MPa), and 100-fold stronger than surgical fibrin glue (0.04 MPa), when
cured in wet-field conditions. In addition to adhesion, phosphoserine creates other novel properties
in bioceramics, including a nanoscale organic/inorganic composite microstructure, and templating
of nanoscale amorphous calcium phosphate nucleation. PM-CPCs are made of the biocompatible
precursors calcium, phosphate, and amino acid, and these represent the first amorphous nano-ceramic
composites that are stable in liquids.
Keywords: cement; tissue adhesive; phosphoserine; self-assembly; amorphous calcium phosphate
(ACP); correlation nuclear magnetic resonance (NMR) spectroscopy; bioinspired; biomaterial
1. Introduction
Calcium phosphate cements (CPCs) are effective bone void fillers, due, in part, to their chemical
similarity to the inorganic phase of bone (hydroxyapatite), which facilitates the deposition of new
extracellular matrix, tissue, and vasculature on the bioceramic surface (osteoconduction). In the
mineral phase of calcified tissues, the proteinacious organic phase creates complex material and
biological properties that are absent from synthetic bioceramics: the hierarchical organization of
organic and inorganic phases into a nanoscale composite, biologically controlled mineralization
(biomineralization), and tissue integration/adhesion [1–4]. Attempts have been made to reproduce
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these complex architectural andmaterial properties in bioceramics by incorporating small biomolecules
(i.e., peptides, organic acids, or molecular moieties) as additives [5–14]. With few notable exceptions,
cement additives [9,10], which act by regulating the surface-driven processes of crystal nucleation,
crystal growth, and cell-mediated dissolution/resorption [1,3,15,16], can only modestly improve the
mechanical strength, microstructural organization, and rate of tissue integration of bioceramics [17].
We have discovered that a simple additive, phosphoserine, can recreate complex architectural
and material properties in alpha tricalcium phosphate (αTCP) cements, reminiscent of native calcified
tissues, and can produce entirely novel properties: strong adhesion to tissue and varied biomaterial
surfaces, enhanced handling and setting, templated mineralization of nanoscale amorphous calcium
phosphate, and stabilization of metastable ceramic phases. There have been only two prior reports of
adhesive cements in the field of calcium phosphate bioceramics [9,10]. In both cases, the mechanisms
underlying adhesion, and the methods by which this phenomenon can be extended to different calcium
phosphates or other materials, are unclear. In this study we have produced phosphoserine-modified
calcium phosphate cements (PM-CPC) by combining αTCP, a metastable ceramic that transforms
into hydroxyapatite over the course of days to weeks in biological fluids [18], with phosphoserine.
PM-CPCs hardened within minutes, rather than the days needed for the unmodified αTCP cement
to cure, to form an organic/inorganic composite of amorphous, nanoscale calcium phosphate and
phosphoserine, and αTCP.
We have evaluated whether PM-CPC meets the requirements for clinical use, as a calcified
tissue adhesive, via mechanical tests on fresh tissues, with test samples being cured under wet-field
conditions [19]. Chemical and structural analysis, with X-ray diffraction and electron microscopy,
revealed that phosphorylated amino acids (i.e., phosphoserine) accelerated the setting, improved the
mechanical strength, and enhanced the handling properties by (a) forming a macroscale organic phase
that covers the surface of αTCP particles, thereby preventing the dissolution or reorganization of
αTCP, and (b) facilitating the nucleation of nanoscale, amorphous calcium phosphate to produce a
nanoscale organic/inorganic composite material. Phosphoserine was selected for this study because it
is predominantly found in phosphoproteins that are involved in a wide range of biological processes;
from adhesion, in marine “bioglues” [20–22], tissue adhesion, cohesion, and load dissipation in
animals, to biomineralization, via matrix proteins [1,3,23], and matrix vesicles [2]. We hypothesized
that some of these interesting biological and chemical properties might be recreated, to a limited extent,
by incorporating phosphoserine into CPCs [8]. Herein, we report on the first class of bioinspired
bioceramics that combine simple phosphorylated amino acids with tricalcium phosphate, to create
novel, complex material properties.
2. Materials and Methods
2.1. Materials
All materials were purchased from Sigma-Aldrich (AB Sigma-Aldrich Sweden, Stockholm,
Sweden), unless otherwise indicated. Monocalcium phosphate monohydrate (MCPM,
Ca(H2PO4)2·H2O) was purchased from Scharlau (Barcelona, Spain). Alpha tricalcium phosphate
(αTCP, Ca3(PO4)2) was synthesized by heating (Carbolyte oven CWF1300, AB Ninolab, Stockholm,
Sweden) calcium carbonate and monocalcium phosphate anhydrous, at a 2:1 molar ratio, on a zirconia
setter plate for 12 h, at 1450 ◦C. After quenching in air, the αTCP powder was dry milled (Reitsch
PM400, AB Ninolab, Stockholm, Sweden) in a 500 mL zirconia milling jar, at 300 RPM for 15 min, with
100 grams of powder per 100 zirconia milling balls (10 mm diameter), and the purity was determined
to be 98% wt% αTCP, with 2% wt% βTCP as an impurity, by Rietveld refinement of X-ray diffraction
patterns (Profex software, PDF# 04-010-4348 αTCP, #01-074-0565 hydroxyapatite, #04-008-8714 βTCP,
#04-007-9734 CaO) [24]. O-phospho-L-serine, hereafter referred to as phosphoserine, (>95%, Flamma
SpA, Bergamo, Italy) was used as received. Fresh adult bovine and porcine tissue was obtained
from Lövsta kött (Uppsala, Sweden), with approval from the Department of Agriculture. Cortical
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tissue from the bovine humeral diaphyseal shaft was cut into cubes (1 cm3) and stored in phosphate
buffered saline at −20 ◦C. The cut surfaces were not polished or treated further. Tendon and cartilage
samples were obtained from the bovine knee and hip joints, respectively, and stored as described for
bone. Porcine skin (freshly harvested adult ears), heart, and liver were cut into strips (1 cm × 2 cm)
and frozen for later use. Collagen films were generously provided by Viscofan GmbH (Weinheim,
Germany).
2.2. PM-CPC Fabrication
Adhesive cements (PM-CPC) were created by premixing powders with defined molar ratios
(mol%) of phosphoserine to αTCP. Unless otherwise indicated, all PM-CPC (%) compositions refer
to mol%. Ultrapure water (18.2 Ω) was added at predetermined liquid-to-powder ratios (L/Ps), and
samples were mixed with a spatula for 20 s. Scanning electron microscope (SEM) samples included:
thin layer fracture samples (0.25 g cured on metal (steel, aluminum) or bone surfaces), and discs (2.0 g,
cured in silicon molds, 8 mm diameter by 4 mm thick). A liquid-to-powder ratio of 0.25 g·mL−1
was used for SEM, compression, and adhesive testing samples, unless otherwise indicated. Samples
were cured at 37 ◦C, in 100% relative humidity for compression or in ultrapure water for adhesive
samples, for 24 h. Though PM-CPCs cured equally well in phosphate buffered saline (PBS), producing
comparable adhesive shear strength, water was selected for testing to avoid confounding effects due
to reprecipitation or dissolution caused by phosphate.
2.3. Mechanical Testing, Characterization
Samples for the adhesive shear test (bone or steel cubes, 1 cm2 contact area) were prepared
by placing a thin layer (0.25 g) of PM-CPC on the surface, clamping the cortical bovine bone cubes
together with universal grips, and submerging into water (37 ◦C, 24 h, calcified tissues) or 100% humid
sealed containers (37 ◦C, 1–4 h, soft tissues). Samples were loaded to failure, on a Shimadzu AGS-X
mechanical testing machine (Shimadzu Europa Gmbh, Duisburg, Germany). Lap shear samples were
prepared by cutting the tissue to strips 1 cm × 2 cm × 0.5 cm thick, with a 1 cm2 adhered surface.
Samples were tested at a crosshead speed of 1 mm per minute (compression and shear, calcified
tissues) or 10 mm per minute (shear, soft tissues). Note that for collagen and liver, tissue samples failed
cohesively before the PM-CPC bond (PM-CPC adhesive strength exceeded the cohesive strength of the
material). Compression samples (cylinders 6 mm × 12 mm, cured as for shear testing) were tested
at a crosshead speed of 1 mm per minute, with a spherically seated platen (Shimadzu #346-50639-32,
Shimadzu Europa Gmbh, Duisburg, Germany). Prior to testing, cylinder surfaces were polished to
1200 grit fineness with silicon carbide polishing paper (Struers A/S, Bromma, Denmark). Cohesion
was demonstrated with a Gilmore needle (#H-3150, Humboldt, IL, USA), using a 113 g load (needle tip
diameter 2.12 mm) on unmodified CPC, and a 453 g load (needle tip diameter 1.06 mm) on PM-CPC.
X-ray diffractograms (XRD) of powder samples were obtained on a Bruker D800 advance (Bruker
Daltonics Scandinavia AB, Solna, Sweden), from 3 to 60 degrees, with a step size of 0.03 degrees per
step, and a dwell time of 0.16 s.
2.4. SEM Analysis
SEM images were obtained on a Merlin field emission SEM (AB Carl Zeiss, Stockholm, Sweden),
with an secondary electron in-lens detector, an acceleration voltage of 3 keV, and 195 pA current, for
adhesive samples, at a working distance of 5 mm. Prior to SEM analysis, samples were sputtered with
a (10 nm thick) coating of gold and palladium (Emitech SC7640, Quorum technologies, Kent, UK), at
2 kV for 40 s.
2.5. Solid-State NMR
All magic-angle-spinning (MAS) nuclear magnetic resonance (NMR) experimentation utilized
a Bruker Avance-III spectrometer and a magnetic field of 9.4 T, which gives Larmor frequencies of
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−400.1 MHz and −162.0 MHz for 1H and 31P, respectively. Cement powders and polycrystalline
O-phospho-L-Serine and L-serine samples were packed in 2.5 mm zirconia rotors and spun at 34.00 kHz.
1H and 31P chemical shifts are quoted relative to neat tetramethylsilane (TMS) and 85% H3PO4 (aq),
respectively. 1H MAS NMR spectra were recorded by single pulses operating at a 1H nutation
frequency νH = 80 kHz and using 4 s relaxation delays.
1H{31P} dipolar-mediated heteronuclear multiple-quantum coherence (D-HMQC) NMR [25]
data were collected from CPCs incorporating 16 mol% of either phosphoserine or serine. 1H–31P
multiple-quantum coherences were generated by one completed SR421 pulse sequence [26] applied
to the protons, which corresponded to an excitation interval of 176 µs. Note that spin-diffusion
due to 1H–1H interactions are suppressed by the SR421 sequence [26]. The dipolar recoupling pulses
operated at νH = 68 kHz, whereas all strong 90
◦/180◦ 1H pulses of the D-HMQC scheme employed
νH ~108 kHz, whereas 83 kHz was used for the
31P 90◦ pulse. For each real/imaginary data-set of
a States-TPPI acquisition [27], typically 20(t1) × 600(t2) time-points were recorded and zero-filled to
128(t1) × 4096(t2) points, prior to 2D Fourier transformation. Relaxation delays of 2 s and dwell-times
of ∆t2 = 7.20 µs were used together with ∆t1 = 117.6 µs and ∆t1 = 176.5 µs for the experiments with
cements incorporating serine and phosphoserine, respectively, whereas a corresponding number of
1536 and 512 accumulated signal transients were recorded for each t1-value. The larger number of
transients used for the serine-bearing cement reflects the lower affinity of serine (as compared with
phosphoserine) to bind to the calcium phosphate component (see Section 3.5).
2.6. Statistics
Statistically significance differences were identified with SPSS software (version 22), with 1-way
ANOVA, using Games-Howell post hoc analysis.
3. Results and Discussion
3.1. PM-CPC Setting and Compressive Strength
PM-CPCs were created by premixing phosphoserine and αTCP powders, with ultrapure water
as the liquid (Figure 1a). Phosphoserine radically accelerated the setting kinetics of αTCP cement;
even small amounts (<5%) of phosphoserine caused αTCP cement to harden and set within minutes,
while unmodified αTCP cement required hours to set, and days to convert to hydroxyapatite. When
the setting and cement cohesion were qualitatively evaluated with a Gilmore needle, PM-CPC easily
supported a 453 g Gilmore needle within 10 min, while αTCP cement lost cohesion under the force of
the lighter, 113 g Gilmore needle (Figure 1b). The compressive strength of the αTCP cement lacking
phosphoserine, prepared under identical conditions as PM-CPC, reached 4.0 MPa, while PM-CPC
reached 12-fold higher strengths (average of 51.4 MPa, 0% vs. 32%, Figure 1c). The L/P ratio of 0.25
was used to ensure all compositions were workable.
Materials 2018, 11, 2492 5 of 15

 
΅

΅
Figure 1. Physical appearance, setting, and compressive strength of phosphoserine-modified calcium
phosphate cements (PM-CPCs). (a) PM-CPCs are liquids, which are easy to handle and mix, unlike
αTCP cements, which are granular, chalky, and challenging to deliver. (b) The rapid cohesive strength
of PM-CPC is visually represented (0% PM-CPC vs. 30% PM-CPC, 0.25 liquid-to-powder ratio (L/P)) by
placing the Gilmore needle after curing/setting for 10 min. (c) The compressive strength of PM-CPCs
with varied phosphoserine concentration (0.25 L/P, box plots represent the minimum, maximum, and
median values, with whiskers denoting the first and third quartiles (25%, 75%)).Statistical analysis
compared each group to the 30% PM-CPC using ANOVA with Games-Howell post hoc analysis, with *
indicating p-values below 0.05, and ** indicating p-value below 0.01.
3.2. PM-CPC Adhesive Strength and Optimal Formulation
The accelerated setting reaction also produced rapid, strong adhesive bonding between PM-CPCs
and calcified tissues, as demonstrated visually in Figure 2a, where bovine cortical bone cubes that
were glued together with PM-CPC and allowed to cure for 20 min, in liquid, were able to support a 4
kg weight (4 kg/cm2 or 0.4 MPa). Though most adhesives require polished, etched, and level surfaces
to bond properly, in the present study, all adhesive testing was conducted under the most challenging
conditions: untreated and unpolished tissue surfaces, and cured in liquid, to approximate actual
clinical conditions. Shear testing was performed with the test rig shown in Figure 2b, after cortical
bovine bone cubes were glued together with PM-CPC and cured in liquid for 24 h. αTCP cements
lacking phosphoserine are reported to produce 0.05 MPa of adhesive shear force [10]. In comparison,
PM-CPC reached as much as 30-fold higher shear strengths (average of 1.8 MPa, 32 mol% PM-CPC,
L/P 0.25, Figure 2c). Even stronger adhesive and compressive strengths were obtained with lower
liquid-to-powder ratios, reaching a maximum strength of 4.8 MPa in shear (average 2.5 MPa), and
110.8 MPa in compression (average 103.5 MPa) (Figure 2d) at a L/P ratio of 0.15 mL/g. The optimal
PM-CPC formulation, based upon the compressive and shear strength results, contained 20–50 mol%
phosphoserine (Figure 1c, Figure 2c). Adhesiveness, particularly to wet and soft tissue surfaces, was a
completely novel and unexpected property for a material that was mostly ceramic (80 wt% ceramic).
The United States FDA has not approved a material for internal use as a bone tissue adhesive, therefore
it is unclear which material is an appropriate standard [19]. Of the tissue adhesives reported in
the scientific literature, PM-CPC outperformed other adhesives that had been proposed for similar
applications. PM-CPC bonded to cortical bone up to 4-fold (4 MPa vs. 1 MPa, dry), and 10-fold stronger
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(4 MPa vs. 0.1–0.3 MPa, wet), under shear, than cyanoacrylates and other natural adhesives [28,29],
respectively, and up to 100-fold stronger than fibrin glue (0.04 MPa) [30].
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Figure 2. PM-CPC bonds to calcified tissues. (a) The adhesive strength of PM-CPC to calcified tissues
is visually represented by a 1 cm2 cortical bone surface, bonded with PM-CPC, supporting 4 kg
(0.4 MPa) after curing/setting for 20 min (inset is an expanded image of the glued bone cube). (b) The
mechanical test rig used for shear testing. (c) The shear strength of cortical bone cubes glued together
with varied compositions of PM-CPC for 24 h, in liquid. (d) The shear and compressive strength of 30%
PM-CPC with varied L/P ratios (Figure 2d, 0.15 to 0.3 L/P) (compression—grey bars; shear—red bars;
differences in shear strength, between liquid-to-powder ratios compared to 0.15 L/P, are indicated
with * (p < 0.05), and ** (p < 0.01), ANOVA with Games-Howell post-hoc). Box plots represent the
minimum, maximum and median value, with whiskers denoting the first and third quartiles (25%,
75%). In Figure 2c, statistical analysis was used to compare each group to the 30% PM-CPC using
ANOVA with Games-Howell post hoc analysis, with * indicating p-values < 0.05. In Figure 2d, the
compression and shear samples were analyzed, separately, with Games-Howell, with * indicating
p-values below 0.05, and ** indicating a p-value below 0.01.
3.3. PM-CPC Adhesion to Soft Tissues and Biomaterials
In addition to the strong adhesion to calcified tissues, PM-CPCs also bonded to a wide range of
other tissue surfaces, including soft tissues, internal organs, synthetic (steel)-, and naturally-derived
(collagen sheets) biomaterials (Figure 3a–d). The failure mode was brittle, which is expected for a
ceramic material, with sharp failure occurring cohesively rather than adhesively (Figure 3e).
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Figure 3. PM-CPC bonds to different tissue types and biomaterials. (a) Representative force/
displacement curves of PM-CPC bonded to different tissues and biomaterials (bone/steel use the right
y-axis (Force); all other tissues/materials use the left y-axis (Force)). Note that the initial displacement
values have been shifted for clarity, while the total displacement remains accurate, for each sample
(i.e., steel samples were displaced approximately 3 mm before failure, though in (a) the start of
displacement has been shifted by 9.5 mm so it no longer overlaps with soft tissue samples). The test
surface area was approximately 1 cm2. Soft tissues and collagen were tested by lap shear, as described
in the Methods section. (b) Representative images of articular cartilage; (c) tendon; (d) or bone after
shear testing to failure, glued to the same tissue type (i.e., articular cartilage to articular cartilage). Note
the thin, white layer of PM-CPC between the two segments of tendon (c). The PM-CPC failure mode
was cohesive, mixed failure (d). In (b–d) 30% PM-CPC was used. Scale bar dimensions are 5 mm,
3 mm, and 2.5 mm for (b), (c), and (d), respectively.
3.4. PM-CPC Physiochemical Analysis of PM-CPC
The adhesive and compressive strength of PM-CPC varied based upon the mole percentage of
phosphoserine. The fracture surface of discs composed of αTCP CPC, or varied PM-CPC compositions,
were compared with scanning electron microscopy (SEM) (Figure 4a–f) to identify how phosphoserine
affected the microstructure and compressive strength. In αTCP CPC, the αTCP remains as coarse,
unreacted granular particles, with reprecipitated nano-hydroxyapatite plate and needle like crystals
covering the particle surface (Figure 4a,c, 0 mol% PM-CPC, L/P 0.25), after 24 h. In contrast, in
phosphoserine-doped CPCs (2 mol% PM-CPC, and 54 mol% PM-CPC, L/P 0.25), phosphoserine
covered the granular surface of αTCP, and formed an organic interlayer (Figure 4b,e, 2 mol% PM-CPC,
L/P 0.25). At low amounts of phosphoserine, where the compressive strength is also low, the
interlayer appears to subsume nanohydroxyapatite; small plate-like crystals can be seen within
the interlayer. At higher concentrations of phosphoserine, where the compressive strength is optimal
(Figure 4c,f, 53 mol% PM-CPC, L/P 0.25), αTCP particles are no longer visible and the entire surface
appears amorphous. Lower magnification SEM images clearly show the evolution from a granular to
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amorphous macrostructure, with increasing phosphoserine (Figure 4a–c), while higher magnification
images of a fracture surface revealed an underlying porous organic architecture, and an amorphous
surface covered with nanoscale mineral (Figure 4f). The cracks that appear on the surface in Figure 4c,f
resulted from the fracture and lyophilization process, during the preparation for SEM imaging.
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Figure 4. SEM images of the fracture surface of discs made of PM-CPCS. (a–c) The microstructure of
PM-CPC changed as the mol% of phosphoserine increased from 0% (a) to 2% (b) to 53% (c); shifting
from agglomerations of αTCP particles (a) to an amorphous solid (c). (d–f) Higher magnification
images (100,000×), from 0% (d) to 2% (e) to 53% (f)) revealed that phosphoserine formed a thin
organic layer that covered the outside of individual αTCP particles, and replaced, or subsumed, the
nanohydroxyapatite that would normally have reprecipitated ((d) vs. (e)). The fracture surface also
revealed that the underlying structure of PM-CPC was porous and organic, while the surface was
composed of an amorphous/ organic layer that contains nanoscale mineral (f). Scale bar dimensions
are indicated for each row; 40 µm (a–c), 40 nm (d–f).
In αTCP CPC cured for 24 h, crystalline peaks for αTCP and hydroxyapatite (black circle and
orange square, respectively, Figure 5a) are present in the X-ray diffractograms. As the concentration
of phosphoserine increased, from 0% to 15% PM-CPC, hydroxyapatite peaks disappeared. In the
range of PM-CPC formulations where the compressive strength is optimized (16% to 52% PM-CPC),
crystalline peaks for both phosphoserine and hydroxyapatite were absent; only crystalline αTCP peaks,
and a significant amorphous region seen in 10–20◦ 2-theta range, are visible. It should be noted that
phosphoserine appears to recrystallize, likely due to supersaturation, at very high concentrations
(80% PM-CPC). Collectively, the XRD data of PM-CPCs, cured for 24 h, suggests that the adhesive
and cohesive strength decreases concurrently with a transition in the αTCP phase from crystalline to
predominantly amorphous (>53% PM-CPC).
Amorphous calcium phosphates are unstable, and they readily convert to more stable phases
in liquid. Since PM-CPCs are largely amorphous, by XRD analysis at higher concentrations of
phosphoserine, we also evaluated whether PM-CPC remained amorphous in liquids or converted
to more stable phases over time. After 14 days of curing, in humid (Figure 5b) or wet conditions
(Figure 5c), αTCP CPCs converted into more stable hydroxyapatite, with more efficient conversion
occurring in wet conditions. However, PM-CPCs with more than 2 mol% phosphoserine retained
αTCP in crystalline form and prevented the development of crystalline hydroxyapatite, even after
14 days in liquid (Figure 5c).
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Figure 5. (a,b,c) X-ray diffractograms of PM-CPC after curing for 1 (a) or 14 (b) days in 100% humidity,
or 14 days in water (c). Crystalline hydroxyapatite peaks (orange squares, a) appeared within 24 h in
αTCP CPCs (0% PM-CPC), while as little as 2–16% phosphoserine inhibited hydroxyapatite formation
and inhibited the dissolution and transformation of αTCP (black circles, a), even after curing for 14 days
in liquid (c). Crystalline hydroxyapatite peaks are indicated by orange squares (PDF# 01-074-0565),
while crystalline αTCP peaks are indicated by black circles (PDF# 04-010-4348).
3.5. The Organic/Inorganic Interface
Solid-state NMR spectroscopy was employed to gain structural insight across a
sub-nanometer-length scale, using D-HMQC [25] 1H{31P} NMR experiments to specifically
probe the organic/inorganic interface of the PC-CPC samples. The 2D NMR spectra displayed in
Figure 6 were recorded from cements incorporating 16 mol% of either phosphoserine or L-serine.
The detected proton signals mainly stem from the organic molecules, as is evident from comparing
the projections of the D-HMQC NMR spectra along the 1H dimension (shown on top of each 2D
NMR spectrum) with their directly excited 1H NMR counterparts obtained from well-crystalline
phosphoserine and serine. The broader 1H signals observed from the CPCs, relative to the
well-crystalline phosphoserine/serine powders, reflect the structural disorder of the organic polymeric
networks in each cement matrix.
The amorphous nature of both the organic and inorganic components that interface each other
was evidenced by the broad signals observed in the projection along the vertical 31P dimension, which
solely reveals chemical shifts associated with orthophosphate groups. The slightly differing peak
maxima along the 31P projection of the D-HMQC spectra from cements incorporating phosphoserine
(~1.4 ppm) and serine (~2.5 ppm) originated from contributions of NMR signals from both organic
and inorganic phosphate groups in the case of phosphoserine (Figure 6a), whereas all resonances
stemmed from inorganic phosphates in the serine-bearing cement (Figure 6b). Notably, the peak
maximum ~2.5 ppm of the latter is close to the shift ~3 ppm typically observed from amorphous
calcium phosphate (ACP), which is known to also be present as a surface layer in both synthetic and
biogenic apatites [31,32].
Altogether, these results demonstrate that the two amorphous organic/inorganic components of
the cement are intimately bonded at a molecular scale, presumably mainly by electrostatic interactions
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and hydrogen bonds. We comment that 31P MAS NMR spectra recorded directly by single pulses
(not shown) reveal a set of sharp peaks from unreacted αTCP, besides the dominating broad resonances
from the amorphous organic/inorganic components. Yet, no resonances from α-TCP are detected
in the HMQC 2D NMR spectra, due to the absence of protons in its structure and the much longer
(>1 nm) distances between the αTCP crystallites and the proton-bearing organic/ACP components, in
full consistency with the SEM results in Figure 4.
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Figure 6. (a,b) 1H{31P} D-HMQC NMR spectra recorded from cements incorporating 16 mol% of
(a) O-phospho-L-Serine and (b) L-serine. NMR signals are only detected from 1H and 31P nuclei
in close spatial proximity (<0.5 nm), where each proton resonance (at chemical shift δH), appearing
along the horizontal dimension of the 2D NMR spectrum, is correlated with its respective 31P NMR
signal (at chemical shift δP) along the vertical spectral dimension. Projections along the
1H and 31P
dimensions are shown at the top and to the right of each 2D NMR spectrum, respectively, whereas the
topmost red traces represent 1Hmagic-angle-spinning (MAS) NMR spectra recorded directly by single
pulses. The 2D NMR spectra from both the phosphoserine and serine cements confirm that all detected
signals originate from amorphous organic/inorganic components, except for a minute (<1% of the total
integrated intensity) and narrow peak (labeled “HA”) at the shift-coordinate {δP, δH} = {3.0, 0.0} ppm,
which stems from well-ordered hydroxyapatite.
3.6. Adhesive Mechanism and Macrostructure of PM-CPC
SEM analysis of small adhesive samples revealed that adhesion occurs via a distinct organic
phase that wetted the substrate surface (Figure 7a). This organic/amorphous surface layer becomes
mineralized as PM-CPC sets and hardens, thereby “cementing” the adhesive interface. Cross-sections
of PM-CPC discs confirmed that the outer surface was morphologically amorphous/organic (as if the
surface were coated with protein or polymer), and heavily mineralized with nanoscale amorphous
calcium phosphate spheres (Figure 7b). The fracture surface of thin layer PM-CPC, seen after shear
testing, confirmed that the outer organic layer is connected to a dense mineral interior that includes
αTCP particles, via a highly porous, organic network (Figure 7c). The honeycomb-like organic network
was composed of mesoscale vesicles (red arrow, Figure 7c), upon which nanoscale calcium phosphate
nucleated. In contrast, αTCP cement without phosphoserine (0% PM-CPC) developed random
aggregations of nanohydroxyapatite, with very different macrostructures (Figure 7d). The excellent
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cohesive properties (compressive strength) of PM-CPC likely arose from mineral nucleation onto
the entanglements within the organic network, thereby creating “mineralized bridges” (Figure 7c) at
network intersections and effectively crosslinking the organic network. The organic network created
macroscale disorder in the final ceramic, similar to what occurs naturally during biomineralization
of amorphous mineral, and during the crystallization of biogenic ceramics [33,34]. Thus, PM-CPCs
appear to be a novel, bioinspired, nanoscale composite of organic and inorganic phases, with what
appears to be a form of hierarchical organization.

 
΅
΅
΅
΅
Figure 7. Adhesive mechanism andmacrostructure of PM-CPC. (a) Adhesion andwetting of a substrate
surface occurred via an organic phase that appeared on the surface of PM-CPC (white arrow, 72%
PM-CPC, aluminum surface). (b) A cross-section of a PM-CPC disc confirmed that the surface appeared
amorphous/organic (white arrow, 16% PM-CPC, 0.25 L/P), though closer inspection revealed that the
organic phase was heavily mineralized with small, spherical clusters of calcium phosphate. The organic
phase extended from the surface to the interior of PM-CPC, in the form of a porous, honeycomb like
network ((b), red arrow). Unreacted αTCP particles appear in the interior of PM-CPC (red dotted line).
(c) A cross-section of the adhesive interface (53% PM-CPC, 0.25 /LP), taken at the fracture interface
of thin layer PM-CPC, after shear testing, revealed the organic network seen in (b), is comprised of
organic (phosphoserine) meso-scale particles, which form an interconnected fibrillar, polymer like
network. Individual meso-scale organic particles that comprise the network can be distinguished
((c) red arrow). (d) In comparison, αTCP cement without phosphoserine (0% PM-CPC, 0.25 /LP)
contains irregular porosity arising from the random aggregation of plate-like hydroxyapatite crystals.
Scale bar dimensions are 2 µm in (a,b); and 200 nm in (c,d).
3.7. Hierarchical Organization and Templating of PM-CPC by Phosphoserine
Based upon the present observations, we propose a self-assembly process that creates the
unique microstructure of PM-CPCs (Figure 8). PM-CPCs occur when phosphoserine and calcium
phosphate (αTCP) are combined in a supersaturated solution. Phosphoserine initially dissolves
during the PM-CPC setting reaction, but in the supersaturated conditions of a cementitious reaction
(phosphoserine concentration exceeds 4 M, while solubility in water is <<1 M, supersaturated levels of
calcium and phosphate also present from dissolving αTCP), phosphoserine is found in both hydrated
(soluble fibrils, Figure 8a) and partially hydrated forms (self-assembled into mesoscale particles or
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molecular clusters to minimize hydration, Figure 8b) [35–37]. Both forms of phosphoserine contribute
to the observed organic network (Figure 8c), where phosphoserine acts as a nucleation initiator
for amorphous calcium phosphate. In Figure 8b,c, the nanoscale mineral appears white, while
the organic matrix appears grey. Mesoscale phosphoserine particles could display a hydrophilic
surface and hydrophobic interior, or vice versa, as occurs with other self-assembled organic structures
(i.e., micelles). In the presence of a charged αTCP particle surface, during the setting reaction, it is
likely that the charged, hydrophilic portion of phosphoserine particles (white spheres, Figure 8b,
top) covers the αTCP grain, thereby attenuating interactions with surrounding aqueous liquids,
which explains how the αTCP phase remains crystalline in PM-CPCs for weeks, even in liquids.
The aggregation and subsequent mineralization of the organic network within PM-CPCs produce
a hierarchical macrostructure. During adhesion, the organic surface layer of PM-CPC initially wets
an adherend substrate surface (Figure 8c), before subsequently mineralizing during the cementitous
setting reaction. Immediately beneath the PM-CPC surface, the organic phase also entangles with, and
connects to, the denser inorganic, mineral interior (Figure 8d). The macroscale disorder created by the
organic network, and the amorphous nature of the nanoscale calcium phosphate that nucleates onto
the network, contribute to the amorphous spectra seen with X-ray diffraction.

΅
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Figure 8. Hierarchical organization and templating of PM-CPC by phosphoserine. The proposed
self-assembly process (top row images) is supported with SEM images from PM-CPC samples (bottom
row images). (a–c) Phosphoserine was observed in two forms: (a) fibrillar (thin layer fracture surface,
2% PM-CPC) and (b) as meso-scale particles (thin layer fracture surface, 53 mol% PM-CPC). (c) In
cementitious reactions phosphoserine self assembles into meso-scale particles, and subsequently
aggregates into an organic network (thin layer fracture surface, 53 mol% PM-CPC). The charged
moieties (phosphate and carboxylate) of phosphoserine serve as nucleation points, which template the
formation of nanoscale amorphous calcium phosphate spheres, seen individually in (b) and covering
the fracture interface in (c). (d) The organic network integrates meso-scale organic and nanoscale
inorganic phases, into a composite material that appears hierarchically organized (16 mol% PM-CPC).
Scale bar: 200 nm for all images.
Adhesion may arise from nanoscale-charged surfaces [38–41], hydrogen bonding [42], and
hydrophobic/hydrophilic surface wetting, which commonly occur with amino acids and peptides [43].
PM-CPCs are nanoscale composites, which include mesoscale organic, and nanoscale inorganic (CPC),
particles. We propose that the high surface energy and charge density associated with nanoscale
calcium phosphate [38–41], and the charged organic layer on the surface of PM-CPC, facilitate the initial
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wetting of a substrate. Subsequent mineralization of the organic surface/interface then effectively
“cements” the adsorbed organic layer to substrate surfaces, thereby partially creating adhesion. As the
organic network within PM-CPC mineralizes, effectively creating crosslinking, the cohesive strength
increases as well.
4. Conclusions
In this study we have demonstrated, for the first time, that phosphoserine transforms αTCP
cements into strong tissue adhesives that rapidly cure, even in wet-field conditions. PM-CPCs can
bond to a diverse array of surfaces, including biomaterials (i.e., metals, polymers), and calcified and
soft tissues. This novel property arises from the unique nano-scale interactions between phosphoserine
and amorphous calcium phosphate, and the hierarchical organization of the organic phase in PM-CPCs.
PM-CPCs combine useful properties from both the organic and inorganic substituents: they exhibit
strong tissue adhesive strength, despite being largely ceramic (60–80 wt% ceramic). Simultaneously,
PM-CPCs with large amounts of organic substituent (phosphoserine, 53% PM-CPC) still produce
compressive strengths that match the native αTCP CPC, and that set/cure within hours rather
than days.
An adhesive with the ability to bond calcified tissues and withstand physiological tensile,
shear, and compressive loading would be appropriate for many clinical applications, including
joint reconstruction (e.g., elbow), osteochondral reconstruction (e.g., articular cartilage in the knee),
and for the reconstruction of catastrophic tissue injuries [19,44]. An adhesive that bonds both soft
and hard tissues could also redress injuries at the hard/soft tissue interface (e.g., tendon to bone).
PM-CPC appears to be a promising biomaterial, suited for numerous clinical applications, that
requires further evaluation as both a tissue adhesive, and a bioceramic. Nevertheless, prior to clinical
trials, it is necessary to document the safety and efficacy during experimental in vitro and in vivo
conditions. Such measures include the determination of the PM-CPC degradation rate, cyto-, and
biocompatibility, temporal changes of adhesive/mechanical strength, and any pro-regenerative effects
at the application site.
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